A patient with chronic bromvalerylurea poisoning showed cerebellar ataxia and peripheral neuropathy. The patient was a 42-year-old Japanese man who developed consciousness disturbance, diplopia, slurred speech, ataxia and gait disturbance after having taken bromvalerylurea for ten years. Magnetic resonance imaging revealed atrophy of the cerebellum and pontine tegmentum.An electrophysiological study revealed decreased motor nerve conduction velocity and amplitude of compoundmuscle action potentials of the right tibial nerve. Histological findings of the left sural nerve indicated a slightly decreased large myelinated fiber diameter, which suggested chronic axonal damage. (Internal Medicine 36: 742-746, 1997) 
Introduction
Bromvalerylurea has been widely used for treating insomnia and for sedation. Since it is obtainable without prescription in Japan, acute bromvalerylurea poisoning is occasionally encountered in forensic cases of suicide or accidental ingestion of the drug. Chronic poisoning is usually due to its abuse. There have been several reports on acute or chronic bromvalerylurea poisoning (1, (3) (4) (5) (6) (7) (8) . Various neurological symptoms are described in these reports, including confusion, delirium, hallucinations, ataxia, ophthalmoplegia, dysarthria, pyramidal tract signs and peripheral neuropathy. However, there has been only one report on pathological findings in the central nervous system in a case of chronic bromvalerylurea poisoning (1) , and the pathophysiology of it is still unknown. Although peripheral nerve lesions are one of the features of chronic bromvalerylurea poisoning, there have been no reports on peripheral nerve pathology.
Here, we report a patient with chronic bromvalerylurea poisoning presenting with cerebellar ataxia and peripheral neuropathy and the findings of a sural nerve biopsy of this patient. To our knowledge, this is the first report on the findings of nerve biopsy in a patient with chronic bromvalerylurea poisoning.
Case Report
A 42-year-old Japanese taxi driver was admitted to our hospital because of delirium, hallucinations, diplopia, dysarthria and gait disturbance. He had been taking bromvalerylurea for ten years to relieve his nervousness and insomnia due to his irregular working hours as a taxi driver. He had no history of alcohol abuse and was not taking any other sedative drugs or anticonvulsants. Since 1 985 , when he took bromvalerylurea for the first time, the dosage was increased gradually, and after 199 1 , he had been taking up to 3,000 mg ofbromvalerylureaper day, which is three times the recommendeddosage. Shortly dizziness, double vision, dysarthria and ataxia developed, but he continued to take the drug because these symptoms disappeared completely in a short time as he ceased to take the drug. However, from May through June 1995, he did not stop taking the drug even though the above symptomsdid not disappear. He was admitted to a local hospital on June 16, 1995 because of difficulty in walking. On admission, he was found to have double vision, dysarthria and difficulty in walking due to ataxia and weakness of the legs. Visual and auditory hallucinations occurred two days after bromvalerylurea was withdrawn. He was transferred to our hospital on June 23, 1995. On physical examination, he showed hyper legdrosis and dryness of the mouth, but no skin eruptions were noted. Neuro- Chronic Bromvalerylurea Poisoning logical examinations revealed confusion and delirium with visual and auditory hallucinations. Although he complained of double vision on lateral gaze, ocular movementwas dysmetric without limitations. His speech was slurred with a scanning rhythm. He had no weakness or atrophy of his upper extremities. The distal parts of his lower extremities were slightly atrophic and both ankle joints were contracted resulting in drop foot. He had weakness in the iliopsoas, tibialis anterior and gastrocnemius muscles. In particular, the strength of the tibialis anterior muscles was severely impaired so that he could not flex his feet dorsally. He could neither stand straight nor walk without support. He showeddysmetric arm movementsand terminal oscillation in the finger to nose test. Skillful movements of the limbs were impaired. Myoclonicmovements were observed in axial regions such as the neck, trunk and proximal part of limbs. Myotatic reflexes were diminished in the patellar and Achilles tendons. No pathological reflexes were observed. He complained of dysesthesia in the distal part of both legs, and paresthesia occurred when his legs were touched. One week after his admission, both the delirium and the hallucinations had disappeared. The double vision, dysarthria and ataxia of the limbs also gradually disappeared. Although he started rehabilitation as soon as possible, the weaknessof the distal parts of the legs remained. His dysesthesia and paresthesia also continued.
The laboratory findings on admission to our hospital are summarized in Table 1 Magnetic resonance imaging (MRI) revealed atrophy of the cerebellar hemisphere and vermis. The pontine tegmentum was also atrophic and the fourth ventricle was dilated (Fig. 1) . Electroencephalography revealed slow a activities of 8 to 9 Hz in the parieto-occipital region with overlapping transient 8 activities in the frontal region. Right median and ulnar motor nerve conduction velocities (MCV)(amplitudes of compound muscle action potentials (CMAP)) were 37.6 m/sec (1 1.0 mV) and 40.0 m/sec (1 1.5 mV), respectively. The MCVof the right tibial nerve was 25.2 m/sec and its CMAPamplitude was 30 \iV, which was severely decreased compared with that in normal subjects. Sensory nerve conduction velocities (SCV) of the right median and ulnar nerves were 52.0 m/sec and 5 1.6 m/ sec, respectively. However, sensory nerve action potentials were not evoked whenthe right sural nerve wasstimulated at the external malleolus. High amplitude and long duration motor units were observed in needle electromyography of the interossei dorsalis, rectus femoris, tibialis anterior and gastrocnemius muscles. Somatosensory evoked potentials (SEPs) were re- corded after median nerve stimulation at the wrist and posterior tibial nerve at the ankle. The recording sites were the cubital fossa, Erb's point, the seventh cervical spinal process and the scalp (C31 of international 10-20 system) for wrist stimulation, and the popliteal fossa, the twelfth spinal process and the scalp (Cz of international 10-20 system) for ankle stimulation. The latency of the N20 potential on the scalp after right median nerve stimulation was 21.76 ms, which was slightly longer than the latency of normal subjects (normal subjects; <20.88 ms).
Potentials after posterior tibial nerve stimulation were neither evoked in the popliteal fossa nor on the thoracic spinal process. The latency of the P39 component of the scalp was 46.1 ms, which was also longer than the latency of normal limit (normal subjects; <42.21 ms). The P100 latencies of the pattern shift visual evoked potentials (VEPs) were prolonged. The latencies were 139.8 ms (right eye stimulation) and 136.8 ms (left eye stimulation). The auditory brainstem responses (ABRs) were recorded after click sounds were given to each ear. The first wavewhich originated from the cochlea was observed but only very small brainstem responses were evoked. The histopathological findings of the left sural nerve biopsy ( Fig. 2A) revealed a slightly decreased fiber density and a slight but uniform decrease in the diameter of large myelinated fibers. There was no thickening of the perineurium or inflammatory cell infiltration. Small numbers of thinly myelinated fibers were observed with normal axons. Onion bulb formations and the grouping of regenerated fibers were not observed. A histogram of the diameters of myelinated fibers in the left sural nerve was madeafter measurementof myelinated axons from a light micrograph (Fig. 3) . Axon diameters ranged from 0.5 jum to 1 1 Jim and were distributed in a unimodal curve with a peak of 4 jam. Analysis of a teased fiber preparation of fifty-seven myelinated fibers revealed segmental demyelination of only 8.8% of the fibers, which is in the normal range. Electron microscopic examination (Fig. 2B ) revealed several Schwann cell subunits having a few collagen pockets and some of them having flattened cytoplasm.
Discussion
There have been several reports on chronic bromvalerylurea poisoning (1, (3) (4) (5) (6) (7) (8) , which is characterized by psychic symptoms such as confusion, delirium and hallucinations and various neurological symptoms including truncal ataxia, ophthalmoplegia, dysarthria, involuntary movements, spastic paraparesis and peripheral neuropathy. In the present case, we observed similar symptoms. However, the psychic symptoms such as hallucinations in this case were observed upon withdrawal of the bromvalerylurea. The diagnosis in this case was confirmed based on the history of bromvalerylurea abuse, Yagishita et al (4) reported enlargement of the fourth ventricle as well as cerebellar atrophy. One patient reported on by Balkomet al exhibited diffuse atrophy of the cerebrum which was also observed in the present case to a moderate degree. Peripheral neuropathy has been reported to occur in some cases of chronic bromvalerylurea poisoning (5 , 6). However, its pathophysiology has not been hitherto described. In the present case, the electrophysiological investigation revealed both sensory and motor peripheral nerve disturbances of the lower extremities: the CMAPamplitudes were very small and the sensory nerve action potentials were not evoked in a right sural nerve in nerve conduction studies. These results revealed that peripheral nerve damage was severe in the legs. The markedly decreased CMAP amplitudes of the right tibial nerve suggested that axonal damage might have occurred in addition to demy- open bars). The mean density ofmyelinated fibers was ll,030/mm3 in a normal control subject and 9,297/mm3 in the patient.
chronic axonal degeneration had taken place following the chronic toxicity to the motor and sensory neurons.
In addition, megalocytic hyperchromic anemia was observed when the patient was admitted to our hospital. Some drugs such as diphenylhydantoin and barbiturates are knownto induce megaloblastic anemia. The mechanismof the induction of anemia was considered to be interruption of the utilization of folic acid (9) . In this case, such pharmacological mechanisms triggered by bromvalerylurea abuse might have occurred even though the serum levels of vitamin B12 and folic acid were normal. The poor nutrition of this patient might have had some effects on the anemia.
Presently, bromvalerylurea is not prescribed as often as in the past. However, it is easily obtainable without prescription and is thought to be widely used. The consumption ofBrovarin® (Nihon-Shinyaku, Ltd.) which accounts for 90% of the bromvalerylurea sold in Japan was 6.7 million grams in 1996 (10) . Physicians should recognize chronic bromvalerylurea poisoning as one of the causes of ataxia and peripheral neuropathy.
